Skip to content

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand

Ifluence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effect

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07102082
Enrollment
160
Registered
2025-08-03
Start date
2025-09-25
Completion date
2027-09-30
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Behaviors

Brief summary

To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.

Detailed description

Primary Objectives: To assess the influence of smokeless tobacco products' modified risk claims on: 1. Product demand (measured as willingness to pay in USD) using an experimental auction approach; and 2. Perceived risk of tobacco-associated diseases as assessed using questionnaire-based measures.

Interventions

BEHAVIORALModified Risk - None

Participants view ads with no modified risk claim

BEHAVIORALModified Risk Claim

Participants view ads with a modified risk claim

Sponsors

Roswell Park Cancer Institute
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Residing in one of the 8 counties of Western New York (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming). * Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year. * Open to trying a non-combusted oral tobacco product. * Have access to a device (ie: computer/tablet/smartphone) with internet capabilities to participate in an online survey study. * Have the ability to read, write, and communicate in English. * Participant must understand the investigational nature of this study and an Independent Ethics Committee/Institutional Review Board approved information sheet prior to receiving any study related procedure

Exclusion criteria

* Plan to quit smoking in the next 30 days. * Use of smokeless tobacco at least weekly in the last 6 months. * Lifetime use (that is, ever used at any time prior to the study) of Copenhagen or General Snus. * Unwilling or unable to follow protocol requirements. * Pregnant or planning to become pregnant (by self report)

Design outcomes

Primary

MeasureTime frameDescription
Demand for cigarettesAfter one session - 1 hourAfter watching a series of advertisements for oral smokeless tobacco products, participants will provide opinions of them, including likelihood of buying product.
Increase in knowlege of tobacco-associated diseasesAfter one session - I hourmulti item assessment questionnaires of perceived harm/risks from products

Countries

United States

Contacts

CONTACTASK RPCI
askroswell@roswellpark.org1-800-767-9355
PRINCIPAL_INVESTIGATORRichard O'Connor

Roswell Park

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 2, 2026